Transient effectiveness of vitamin D2 therapy in pediatric cystic fibrosis patients

J Cyst Fibros. 2010 Mar;9(2):143-9. doi: 10.1016/j.jcf.2010.01.002. Epub 2010 Feb 8.

Abstract

Background: The effectiveness of current treatment recommendations for vitamin D insufficiency in children with CF is unknown. Therefore, we assessed the effectiveness of vitamin D(2) 50,000 IU once daily for 28 days for vitamin D insufficiency.

Methods: Retrospective chart review of pediatric CF patients from 2006-2008. Vitamin D(2) 50,000 IU daily for 28 days was given to patients with 25-OHD <30 ng/mL and repeat 25-OHD levels were obtained after completion of therapy.

Results: One hundred forty-seven levels from 97 individuals were assessed. Success of treatment was 54% (n=80/147). Seventeen of 39 patients (43%) followed for an additional 6-18 months were able to maintain levels of >or=30 ng/mL.

Conclusions: Vitamin D(2) 50,000 IU daily for 28 days was effective in correcting vitamin D insufficiency in approximately 50% of subjects. However, almost half of successfully treated patients were unable to maintain normal 25-OHD levels >6 months after completion of therapy, implying that this effect is transient.

MeSH terms

  • 25-Hydroxyvitamin D 2 / blood
  • Adolescent
  • Calcifediol / blood
  • Child
  • Child, Preschool
  • Cystic Fibrosis / complications*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Ergocalciferols / administration & dosage*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Prevalence
  • Retrospective Studies
  • Seasons
  • Time Factors
  • Treatment Outcome
  • Vitamin D Deficiency / blood
  • Vitamin D Deficiency / complications*
  • Vitamin D Deficiency / drug therapy*
  • Vitamin D Deficiency / epidemiology
  • Vitamins / administration & dosage*

Substances

  • Ergocalciferols
  • Vitamins
  • 25-Hydroxyvitamin D 2
  • Calcifediol